ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Low Dose of Sucralose Alter Gut Microbiome in Mice.

低用量スクラロースがマウスの腸内細菌叢を変化させる (機械翻訳の邦題)

Frontiers in nutrition2022Zheng Z, Xiao Y, Ma L, et al.
研究デザインその他の原著論文
対象未確定

記録の確認項目

研究デザイン
その他の原著論文
対象
未確定
出版年
2022
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

スクラロースは非栄養性人工甘味料であり、血糖値や体重増加の抑制目的で食品や飲料に使用される。本研究では、マウスに4段階の濃度(0.0003、0.003、0.03、0.3 mg/mL)のスクラロースを16週間投与し、腸内細菌叢への影響を調べた。0.3 mg/mLはFDAの許容一日摂取量(ADI)に相当する。その結果、スクラロース投与は体重を変化させず、回腸と結腸でリンパ球凝集を引き起こし、腸管バリア機能に影響を与えた。16S rRNA遺伝子シーケンス解析により、特に低濃度(T1)とADI濃度(T4)で腸内細菌叢の組成が有意に変化した。T4群の盲腸ではプロバイオティクス(LachnoclostridiumやLachnospiraceae)の減少が、T1およびT4群では糖尿病と正の相関が報告されているAllobaculumの増加が認められた。さらに、Tenacibaculum、Ruegeria、Staphylococcusなどの潜在的な病原菌も増加した。これらの結果から、低用量のスクラロースでもADIレベルと同等の悪影響を及ぼすことが示唆された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Sucralose is a non-nutritive artificial sweetener (NNS) used in foods or beverages to control blood glucose levels and body weight gain. The consumption of NNS has increased in recent years over the world, and many researches have indicated long-term sucralose administration altered the gut microbiome composition of mice. These studies all focus on the US Food and Drug Administration (FDA) defined acceptable daily intake (ADI), approximately 5 mg/kg BW/day for human. In our study, mice were given with T1-4 (0.0003, 0.003, 0.03, and 0.3 mg/mL) of sucralose, respectively, Control group mice were given normal water. In particular, 0.3 mg/mL of sucralose was equal to the ADI (5 mg/kg BW/day). After 16 weeks, all mice were weighted and sacrificed, the liver of each mouse was isolated and weighed, segments of jejunum, ileum and colon were collected for H&E-stained. The contents of jejunum, ileum, cecum and colon were collected for 16S rRNA gene sequencing. The results showed sucralose administration affects the intestinal barrier function evidenced by distinct lymphocyte aggregation in ileum and colon while not change the mice body weight. The 16S rRNA gene sequencing of the mice gut microbiome suggested sucralose administration significantly changed the composition of gut microbiota, especially in T1 and T4 group. For example, a reduction of probiotics abundance (Lachnoclostridium and Lachnospiraceae) was found in cecum of T4 group mice compared with Control group. On the other hand, Allobaculum, which was reported positively correlated with diabetes, was increased in the T1 and T4 group. In addition, the potential pathogens, including Tenacibaculum, Ruegeria, Staphylococcus were also increased in jejunum, ileum and colon by sucralose administration in T1 and T4 group. These new findings indicate that low dose of sucralose (T1) alter gut microbiome in mice, and these adverse health effects are equal to ADI level (T4). Overall, our study provides guidance and suggestions for the use of sucralose in foods and beverages.

DOI 10.3389/fnut.2022.848392

PMID 35284433

原文・出典を見る →